{"gene":"PNPLA1","run_date":"2026-06-10T06:43:35","timeline":{"discoveries":[{"year":2012,"finding":"PNPLA1 mutations (including a premature stop codon in dogs, and missense/nonsense mutations in the catalytic domain in humans) cause autosomal recessive congenital ichthyosis, establishing PNPLA1 as essential for epidermal lipid barrier formation.","method":"Genome-wide association study in dogs, Sanger sequencing in human patients, histological and localization experiments","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic identification in two species with functional follow-up, replicated across multiple families and labs","pmids":["22246504"],"is_preprint":false},{"year":2017,"finding":"PNPLA1 is a transacylase that catalyzes the final step of ω-O-acylceramide synthesis by esterifying ω-hydroxyceramide with linoleic acid derived from triglyceride; ichthyosis-associated mutant forms of PNPLA1 show reduced or absent transacylase activity in cell-based and in vitro assays.","method":"Cell-based acylceramide production assays, in vitro enzyme assays with recombinant PNPLA1, active-site mutagenesis analysis of patient-derived variants","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with substrate, cell-based assays, mutagenesis of disease variants, replicated by independent lab (PMID:28248300)","pmids":["28248318","28248300"],"is_preprint":false},{"year":2017,"finding":"Keratinocyte-specific or global Pnpla1 knockout in mice causes neonatal lethality due to severe epidermal permeability barrier defects, with near-complete absence of acylceramides, acylglucosylceramides, and O-acyl-ω-hydroxy fatty acids in epidermis and reciprocal accumulation of their precursors, confirming PNPLA1 catalyzes ω-O-esterification with linoleic acid in vivo.","method":"Keratinocyte-specific and global knockout mouse models, lipidomic analysis of stratum corneum, electron microscopy of intercellular lipid lamellae","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO with defined biochemical phenotype, confirmed by two independent groups","pmids":["28248300","28369476"],"is_preprint":false},{"year":2017,"finding":"PNPLA1 is specifically expressed in differentiated keratinocytes; Pnpla1-deficient epidermis shows defective lipid coverage of the cornified envelope and disorganized extracellular lipid matrix, linking PNPLA1 enzymatic activity to cornified envelope formation.","method":"Knockout mouse analysis, immunohistochemistry, lipid mass spectrometry, analysis of patient stratum corneum","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — KO mouse and patient tissue with multiple orthogonal readouts","pmids":["28369476"],"is_preprint":false},{"year":2018,"finding":"ABHD5 (CGI-58) acts as a coactivator of PNPLA1 by physically interacting with PNPLA1 and recruiting it to cytosolic lipid droplets where its triglyceride substrate resides, thereby stimulating PNPLA1-catalyzed acylceramide production; disease-associated ABHD5 missense mutations fail to enhance PNPLA1 activity.","method":"Co-immunoprecipitation, cell-based acylceramide production assay, indirect immunofluorescence microscopy, immunoelectron microscopy","journal":"Journal of lipid research","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal interaction, localization, and functional assay, replicated independently (PMID:30527376)","pmids":["30361410","30527376"],"is_preprint":false},{"year":2018,"finding":"ABHD5 co-expression causes PNPLA1 to localize on lipid droplet membranes or their periphery (rather than dispersed in the cytosol); under high co-expression, lipid droplets disappear and appear to transform into vesicles or become incorporated into the ER, suggesting ABHD5 presents triglyceride substrate to PNPLA1.","method":"Indirect immunofluorescence microscopy, immunoelectron microscopy in HeLa cells with co-expression system","journal":"Journal of dermatological science","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — localization data with functional correlation, single lab, two imaging methods","pmids":["30527376"],"is_preprint":false},{"year":2018,"finding":"PNPLA1 mutations (p.Y245del and p.D172N) in ARCI patient fibroblasts cause abnormal intracellular lipid droplet accumulation associated with decreased LC3 expression and reduced autophagosome formation and autophagosome-lysosome fusion, indicating a role for PNPLA1 in lipophagy-mediated lipid droplet regulation.","method":"Fluorescence staining (BODIPY), immunocytochemistry, immunoblotting, siRNA knockdown of PNPLA1 in control fibroblasts","journal":"Journal of dermatological science","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — patient fibroblasts plus siRNA knockdown, single lab, multiple readouts but mechanism not fully reconstituted","pmids":["30655104"],"is_preprint":false},{"year":2022,"finding":"Fifteen of sixteen tested ichthyosis-associated PNPLA1 missense mutations cause complete loss of acylceramide-producing activity in a cell-based assay; one mutation (C216R) only weakly reduces activity, correlating with milder patient symptoms. Mutants with no activity show variable intracellular localization: some localize to lipid droplets (S19L, D172N), others partially (eight mutants), and five remain cytosolic, indicating that lipid droplet localization is necessary but not sufficient for activity.","method":"Cell-based acylceramide production assay with co-overexpression, indirect immunofluorescence microscopy","journal":"Journal of dermatological science","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — systematic mutagenesis of 16 patient variants with both functional and localization readouts, single lab but comprehensive","pmids":["35970721"],"is_preprint":false},{"year":2023,"finding":"Recombinant truncated PNPLA1 (expressed in E. coli) catalyzes acyl transfer from trilinolein and dilinolein to ω-hydroxyceramide, ω-hydroxyglucosylceramide, and ω-hydroxy acid acceptors, forming acylceramide, glucosyl-acylceramide, and acyl acid respectively; PNPLA1 transfers linoleate with approximately 3:1 selectivity over oleate, explaining in vivo linoleic acid enrichment of acylceramides.","method":"In vitro enzyme assay with purified recombinant PNPLA1, liposomal substrates, HPLC-UV and LC-MS product analysis","journal":"Journal of lipid research","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with purified recombinant enzyme and defined substrates, substrate selectivity quantified","pmids":["37087101"],"is_preprint":false},{"year":2024,"finding":"siRNA-mediated knockdown of PNPLA1 in differentiated normal human keratinocytes reduces levels of both LA-esterified and GLA-esterified ceramide 1 subspecies and accumulates non-esterified ω-hydroxy ceramide precursors, demonstrating that PNPLA1 is responsible for esterification of γ-linolenic acid (GLA) as well as linoleic acid to ceramide 1.","method":"siRNA knockdown in differentiated normal human keratinocytes, LC-MS lipidomic quantification of ceramide subspecies","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean knockdown with substrate accumulation and product depletion, single lab","pmids":["38340658"],"is_preprint":false},{"year":2025,"finding":"ABHD5 disease-associated mutations disrupt PNPLA1 function by two distinct mechanisms: (i) mutations in the PNPLA1-binding region of ABHD5 impair PNPLA1 recruitment to lipid droplets; (ii) mutations in potential perilipin-binding domains prevent ABHD5 from associating with lipid droplets, indirectly disrupting PNPLA1 localization. Restoring co-localization of ABHD5 mutants with PNPLA1 in proteoliposomes rescues full PNPLA1 enzyme activity, indicating that spatial proximity (not direct binding) is sufficient for PNPLA1 activation.","method":"Analysis of seven ABHD5 missense mutations in cell-based assays, immunofluorescence microscopy, proteoliposome reconstitution assay","journal":"Journal of lipid research","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — reconstitution in proteoliposomes plus cell-based localization and activity assays, mechanistic dissection of two distinct pathways","pmids":["40818613"],"is_preprint":false}],"current_model":"PNPLA1 is a CoA-independent transacylase expressed specifically in differentiated keratinocytes that catalyzes the final step of ω-O-acylceramide biosynthesis by transferring linoleic acid (with ~3:1 selectivity over oleate) from triglyceride donors to ω-hydroxyceramide acceptors; it is recruited to cytosolic lipid droplets (its substrate reservoir) by the coactivator ABHD5, which stimulates PNPLA1 activity through spatial co-localization rather than obligate direct binding, and loss-of-function mutations in either PNPLA1 or ABHD5 abolish acylceramide production and disrupt the stratum corneum permeability barrier, causing autosomal recessive congenital ichthyosis."},"narrative":{"mechanistic_narrative":"PNPLA1 is a CoA-independent transacylase expressed specifically in differentiated keratinocytes that catalyzes the final, committed step of ω-O-acylceramide biosynthesis required to build the epidermal permeability barrier [PMID:28248318, PMID:28248300, PMID:28369476]. Working with purified recombinant enzyme, PNPLA1 transfers fatty acid from triglyceride donors (trilinolein and dilinolein) onto ω-hydroxyceramide, ω-hydroxyglucosylceramide, and ω-hydroxy acid acceptors, generating acylceramide, glucosyl-acylceramide, and acyl acid; it selects linoleate over oleate with ~3:1 preference, accounting for the linoleic acid enrichment of epidermal acylceramides, and also esterifies γ-linolenic acid onto ceramide 1 [PMID:37087101, PMID:38340658]. In keratinocyte-specific and global Pnpla1 knockout mice, acylceramides and their O-acyl-ω-hydroxy fatty acid components are nearly absent while precursors accumulate, producing a disorganized extracellular lipid matrix, defective lipid coverage of the cornified envelope, and neonatal lethality from barrier failure [PMID:28248300, PMID:28369476]. PNPLA1 acquires its triglyceride substrate at cytosolic lipid droplets, to which it is recruited by the coactivator ABHD5 (CGI-58); spatial co-localization of the two proteins at the droplet — rather than obligate direct binding — is sufficient to activate PNPLA1, as shown by proteoliposome reconstitution, and ABHD5 disease mutations abolish activation by impairing either PNPLA1 recruitment or ABHD5's own droplet association [PMID:30361410, PMID:30527376, PMID:40818613]. Loss-of-function mutations in the catalytic domain of PNPLA1 cause autosomal recessive congenital ichthyosis, with the great majority of patient missense variants completely abolishing acylceramide-producing activity [PMID:22246504, PMID:35970721].","teleology":[{"year":2012,"claim":"Established PNPLA1 as a gene essential for the epidermal lipid barrier, answering whether it has a non-redundant role in skin physiology.","evidence":"GWAS in dogs and Sanger sequencing of human ARCI patients with histological follow-up","pmids":["22246504"],"confidence":"High","gaps":["Did not define the biochemical reaction catalyzed","No substrate or product identified","Subcellular site of action unknown"]},{"year":2017,"claim":"Defined PNPLA1's molecular function as the transacylase catalyzing the final ω-O-esterification step of acylceramide synthesis, linking enzyme activity directly to disease mutations.","evidence":"Cell-based and in vitro transacylase assays with recombinant PNPLA1 plus active-site mutagenesis of patient variants, confirmed by KO mouse lipidomics and electron microscopy of lipid lamellae","pmids":["28248318","28248300","28369476"],"confidence":"High","gaps":["Source and presentation of the triglyceride substrate not yet defined","Acceptor substrate range incompletely mapped","Fatty acid selectivity not quantified"]},{"year":2018,"claim":"Identified ABHD5 (CGI-58) as the coactivator that recruits PNPLA1 to lipid droplets, answering how the enzyme accesses its triglyceride substrate.","evidence":"Co-immunoprecipitation, cell-based acylceramide assays, and immunofluorescence/immunoelectron microscopy in co-expression systems","pmids":["30361410","30527376"],"confidence":"High","gaps":["Whether direct binding or spatial proximity drives activation not resolved","Mechanism of triglyceride presentation inferred from imaging only"]},{"year":2018,"claim":"Proposed an additional role for PNPLA1 in lipophagy-mediated lipid droplet turnover, raising the question of whether barrier defects involve autophagy.","evidence":"BODIPY staining, immunoblotting, and siRNA knockdown in ARCI patient and control fibroblasts","pmids":["30655104"],"confidence":"Medium","gaps":["Mechanism not reconstituted; autophagy link is correlative","Relationship to transacylase activity unclear","Observed in fibroblasts rather than keratinocytes"]},{"year":2022,"claim":"Systematically tied PNPLA1 patient variants to loss of catalytic activity and showed lipid droplet localization is necessary but not sufficient for activity.","evidence":"Cell-based acylceramide assay and immunofluorescence across sixteen ichthyosis-associated missense mutations","pmids":["35970721"],"confidence":"High","gaps":["Single-lab dataset","Structural basis for activity loss not determined","Why some inactive mutants still localize to droplets unexplained"]},{"year":2023,"claim":"Reconstituted PNPLA1 transacylase activity with purified enzyme and defined substrates, quantifying its ~3:1 linoleate-over-oleate selectivity and broad acceptor range.","evidence":"In vitro assays with E. coli-expressed truncated recombinant PNPLA1, liposomal substrates, and HPLC-UV/LC-MS product analysis","pmids":["37087101"],"confidence":"High","gaps":["Used truncated enzyme rather than full-length","Structural determinants of fatty acid selectivity not defined","Role of ABHD5 in the purified system not tested here"]},{"year":2024,"claim":"Extended PNPLA1's acceptor/donor scope to γ-linolenic acid esterification of ceramide 1 in human keratinocytes, broadening its substrate repertoire beyond linoleic acid.","evidence":"siRNA knockdown in differentiated normal human keratinocytes with LC-MS lipidomic quantification of ceramide subspecies","pmids":["38340658"],"confidence":"Medium","gaps":["Single-lab knockdown study","Relative physiological contribution of GLA vs LA esterification unquantified"]},{"year":2025,"claim":"Resolved the mechanism of ABHD5 activation, showing spatial proximity rather than direct binding is sufficient to activate PNPLA1 and dissecting two distinct mutational failure modes.","evidence":"Cell-based assays and immunofluorescence of seven ABHD5 missense mutations plus proteoliposome reconstitution rescuing PNPLA1 activity by restoring co-localization","pmids":["40818613"],"confidence":"High","gaps":["Molecular details of substrate hand-off at the droplet surface remain undefined","Role of perilipins in droplet targeting inferred, not directly tested"]},{"year":null,"claim":"A high-resolution structural model of PNPLA1, its catalytic mechanism, and the geometry of triglyceride/ceramide substrate engagement at the lipid droplet interface remain to be established.","evidence":"","pmids":[],"confidence":"High","gaps":["No experimental structure of PNPLA1","Structural basis of linoleate selectivity unknown","How autophagy/lipophagy role integrates with transacylase function unresolved"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[1,2,8,9]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[1,8]}],"localization":[{"term_id":"GO:0005811","term_label":"lipid droplet","supporting_discovery_ids":[4,5,7]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[5,7]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[1,2,8]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,2,3]}],"complexes":[],"partners":["ABHD5"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q8N8W4","full_name":"Omega-hydroxyceramide transacylase","aliases":["Patatin-like phospholipase domain-containing protein 1"],"length_aa":532,"mass_kda":57.9,"function":"Omega-hydroxyceramide transacylase involved in the synthesis of omega-O-acylceramides (esterified omega-hydroxyacyl-sphingosine; EOS), which are extremely hydrophobic lipids involved in skin barrier formation (PubMed:27751867, PubMed:28248318). Catalyzes the last step of the synthesis of omega-O-acylceramides by transferring linoleic acid from triglycerides to an omega-hydroxyceramide (PubMed:27751867, PubMed:28248318). Omega-O-acylceramides, are required for the biogenesis of lipid lamellae in the stratum corneum and the formation of the cornified lipid envelope which are essential for the epidermis barrier function (PubMed:22246504, PubMed:27751867, PubMed:28248318). These lipids also play a role in keratinocyte differentiation (By similarity). May also act on omega-hydroxylated ultra-long chain fatty acids (omega-OH ULCFA) and acylglucosylceramides (GlcEOS) (By similarity)","subcellular_location":"Cytoplasm","url":"https://www.uniprot.org/uniprotkb/Q8N8W4/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PNPLA1","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/PNPLA1","total_profiled":1310},"omim":[{"mim_id":"615024","title":"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 10; ARCI10","url":"https://www.omim.org/entry/615024"},{"mim_id":"612121","title":"PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 1; PNPLA1","url":"https://www.omim.org/entry/612121"},{"mim_id":"242300","title":"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1; ARCI1","url":"https://www.omim.org/entry/242300"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"skin 1","ntpm":22.5}],"url":"https://www.proteinatlas.org/search/PNPLA1"},"hgnc":{"alias_symbol":["FLJ38755","dJ50J22.1"],"prev_symbol":[]},"alphafold":{"accession":"Q8N8W4","domains":[{"cath_id":"-","chopping":"13-282","consensus_level":"high","plddt":90.3484,"start":13,"end":282}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8N8W4","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8N8W4-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8N8W4-F1-predicted_aligned_error_v6.png","plddt_mean":63.75},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PNPLA1","jax_strain_url":"https://www.jax.org/strain/search?query=PNPLA1"},"sequence":{"accession":"Q8N8W4","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8N8W4.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8N8W4/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8N8W4"}},"corpus_meta":[{"pmid":"22246504","id":"PMC_22246504","title":"PNPLA1 mutations cause autosomal recessive congenital ichthyosis in golden retriever dogs and humans.","date":"2012","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22246504","citation_count":198,"is_preprint":false},{"pmid":"28248300","id":"PMC_28248300","title":"PNPLA1 has a crucial role in skin barrier function by directing acylceramide biosynthesis.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/28248300","citation_count":111,"is_preprint":false},{"pmid":"28248318","id":"PMC_28248318","title":"PNPLA1 is a transacylase essential for the generation of the skin barrier lipid ω-O-acylceramide.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/28248318","citation_count":106,"is_preprint":false},{"pmid":"30527376","id":"PMC_30527376","title":"Molecular mechanism of the ichthyosis pathology of Chanarin-Dorfman syndrome: Stimulation of PNPLA1-catalyzed ω-O-acylceramide production by ABHD5.","date":"2018","source":"Journal of dermatological science","url":"https://pubmed.ncbi.nlm.nih.gov/30527376","citation_count":47,"is_preprint":false},{"pmid":"30290227","id":"PMC_30290227","title":"The role of PNPLA1 in ω-O-acylceramide synthesis and skin barrier function.","date":"2018","source":"Biochimica et biophysica acta. Molecular and cell biology of lipids","url":"https://pubmed.ncbi.nlm.nih.gov/30290227","citation_count":46,"is_preprint":false},{"pmid":"30361410","id":"PMC_30361410","title":"ABHD5 stimulates PNPLA1-mediated ω-O-acylceramide biosynthesis essential for a functional skin permeability barrier.","date":"2018","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/30361410","citation_count":46,"is_preprint":false},{"pmid":"28369476","id":"PMC_28369476","title":"PNPLA1 defects in patients with autosomal recessive congenital ichthyosis and KO mice sustain PNPLA1 irreplaceable function in epidermal omega-O-acylceramide synthesis and skin permeability barrier.","date":"2017","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28369476","citation_count":44,"is_preprint":false},{"pmid":"27884779","id":"PMC_27884779","title":"Gene-Targeted Next Generation Sequencing Identifies PNPLA1 Mutations in Patients with a Phenotypic Spectrum of Autosomal Recessive Congenital Ichthyosis: The Impact of Consanguinity.","date":"2016","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/27884779","citation_count":31,"is_preprint":false},{"pmid":"28093717","id":"PMC_28093717","title":"Sixteen novel mutations in PNPLA1 in patients with autosomal recessive congenital ichthyosis reveal the importance of an extended patatin domain in PNPLA1 that is essential for proper human skin barrier function.","date":"2017","source":"The British journal of dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/28093717","citation_count":28,"is_preprint":false},{"pmid":"30655104","id":"PMC_30655104","title":"Impairment of lipophagy by PNPLA1 mutations causes lipid droplet accumulation in primary fibroblasts of Autosomal Recessive Congenital Ichthyosis patients.","date":"2018","source":"Journal of dermatological science","url":"https://pubmed.ncbi.nlm.nih.gov/30655104","citation_count":12,"is_preprint":false},{"pmid":"37087101","id":"PMC_37087101","title":"Recombinant PNPLA1 catalyzes the synthesis of acylceramides and acyl acids with selective incorporation of linoleic acid.","date":"2023","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/37087101","citation_count":8,"is_preprint":false},{"pmid":"29738490","id":"PMC_29738490","title":"Prevalence of PNPLA1 Gene Mutation in 48 Breeding Golden Retriever Dogs.","date":"2018","source":"Veterinary sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29738490","citation_count":7,"is_preprint":false},{"pmid":"27237723","id":"PMC_27237723","title":"Autosomal recessive congenital ichthyosis due to PNPLA1 mutation in a golden retriever-poodle cross-bred dog and the effect of topical therapy.","date":"2016","source":"Veterinary dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/27237723","citation_count":7,"is_preprint":false},{"pmid":"31120544","id":"PMC_31120544","title":"Novel and Recurrent PNPLA1 Mutations in Spanish Patients with Autosomal Recessive Congenital Ichthyosis; Evidence of a Founder Effect.","date":"2019","source":"Acta dermato-venereologica","url":"https://pubmed.ncbi.nlm.nih.gov/31120544","citation_count":7,"is_preprint":false},{"pmid":"34899144","id":"PMC_34899144","title":"Variants in the PNPLA1 Gene in Families with Autosomal Recessive Congenital Ichthyosis Reveal Clinical Significance.","date":"2021","source":"Molecular syndromology","url":"https://pubmed.ncbi.nlm.nih.gov/34899144","citation_count":6,"is_preprint":false},{"pmid":"29624231","id":"PMC_29624231","title":"Identification of two novel PNPLA1 mutations in Turkish families with autosomal recessive congenital ichthyosis.","date":"2017","source":"The Turkish journal of pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/29624231","citation_count":6,"is_preprint":false},{"pmid":"35893253","id":"PMC_35893253","title":"PNPLA1-Mediated Acylceramide Biosynthesis and Autosomal Recessive Congenital Ichthyosis.","date":"2022","source":"Metabolites","url":"https://pubmed.ncbi.nlm.nih.gov/35893253","citation_count":5,"is_preprint":false},{"pmid":"35970721","id":"PMC_35970721","title":"Impaired production of skin barrier lipid acylceramides and abnormal localization of PNPLA1 due to ichthyosis-causing mutations in PNPLA1.","date":"2022","source":"Journal of dermatological science","url":"https://pubmed.ncbi.nlm.nih.gov/35970721","citation_count":5,"is_preprint":false},{"pmid":"31833240","id":"PMC_31833240","title":"Targeted regions sequencing identified four novel PNPLA1 mutations in two Chinese families with autosomal recessive congenital ichthyosis.","date":"2019","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31833240","citation_count":5,"is_preprint":false},{"pmid":"40818613","id":"PMC_40818613","title":"Defective targeting of PNPLA1 to lipid droplets causes ichthyosis in ABHD5-syndromic epidermal differentiation disorder.","date":"2025","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/40818613","citation_count":4,"is_preprint":false},{"pmid":"36647593","id":"PMC_36647593","title":"Novel Pathogenic Mutation of PNPLA1 Identified in Autosomal Recessive Congenital Ichthyosis: A Case Report.","date":"2022","source":"Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih","url":"https://pubmed.ncbi.nlm.nih.gov/36647593","citation_count":3,"is_preprint":false},{"pmid":"38340658","id":"PMC_38340658","title":"PNPLA1 knockdown inhibits esterification of γ-linolenic acid to ceramide 1 in differentiated keratinocytes.","date":"2024","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/38340658","citation_count":2,"is_preprint":false},{"pmid":"40545863","id":"PMC_40545863","title":"The First Reported Japanese Case of PNPLA1-Nonsyndromic Epidermal Differentiation Disorder (PNPLA1-nEDD) Associated With an Unreported 92-Base-Pair Duplication Variant.","date":"2025","source":"Experimental dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/40545863","citation_count":2,"is_preprint":false},{"pmid":"40150930","id":"PMC_40150930","title":"Intragenic PNPLA1 duplication in Labrador retrievers with nonepidermolytic ichthyosis.","date":"2025","source":"Veterinary dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/40150930","citation_count":2,"is_preprint":false},{"pmid":"32924119","id":"PMC_32924119","title":"[Analysis of PNPLA1 gene mutation in a child with ichthyosis].","date":"2020","source":"Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32924119","citation_count":1,"is_preprint":false},{"pmid":"41530952","id":"PMC_41530952","title":"Progressive symmetrical erythrokeratoderma associated with biallelic PNPLA1 variants.","date":"2026","source":"The British journal of dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/41530952","citation_count":1,"is_preprint":false},{"pmid":"41655508","id":"PMC_41655508","title":"Genome-wide identification of the phospholipase gene family in Panax notoginseng and functional analysis of PnPLA1-8 response to Fusarium oxysporum infection.","date":"2026","source":"Plant physiology and biochemistry : PPB","url":"https://pubmed.ncbi.nlm.nih.gov/41655508","citation_count":0,"is_preprint":false},{"pmid":"41964248","id":"PMC_41964248","title":"Mutation Analysis in Ten Cases With PNPLA1-Nonsyndromic Epidermal Differentiation Disorder: Evidence of a Founder Effect.","date":"2026","source":"The Journal of dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/41964248","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":16634,"output_tokens":2945,"usd":0.047038,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":10225,"output_tokens":3025,"usd":0.063375,"stage2_stop_reason":"end_turn"},"total_usd":0.110413,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2012,\n      \"finding\": \"PNPLA1 mutations (including a premature stop codon in dogs, and missense/nonsense mutations in the catalytic domain in humans) cause autosomal recessive congenital ichthyosis, establishing PNPLA1 as essential for epidermal lipid barrier formation.\",\n      \"method\": \"Genome-wide association study in dogs, Sanger sequencing in human patients, histological and localization experiments\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic identification in two species with functional follow-up, replicated across multiple families and labs\",\n      \"pmids\": [\"22246504\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"PNPLA1 is a transacylase that catalyzes the final step of ω-O-acylceramide synthesis by esterifying ω-hydroxyceramide with linoleic acid derived from triglyceride; ichthyosis-associated mutant forms of PNPLA1 show reduced or absent transacylase activity in cell-based and in vitro assays.\",\n      \"method\": \"Cell-based acylceramide production assays, in vitro enzyme assays with recombinant PNPLA1, active-site mutagenesis analysis of patient-derived variants\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with substrate, cell-based assays, mutagenesis of disease variants, replicated by independent lab (PMID:28248300)\",\n      \"pmids\": [\"28248318\", \"28248300\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Keratinocyte-specific or global Pnpla1 knockout in mice causes neonatal lethality due to severe epidermal permeability barrier defects, with near-complete absence of acylceramides, acylglucosylceramides, and O-acyl-ω-hydroxy fatty acids in epidermis and reciprocal accumulation of their precursors, confirming PNPLA1 catalyzes ω-O-esterification with linoleic acid in vivo.\",\n      \"method\": \"Keratinocyte-specific and global knockout mouse models, lipidomic analysis of stratum corneum, electron microscopy of intercellular lipid lamellae\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO with defined biochemical phenotype, confirmed by two independent groups\",\n      \"pmids\": [\"28248300\", \"28369476\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"PNPLA1 is specifically expressed in differentiated keratinocytes; Pnpla1-deficient epidermis shows defective lipid coverage of the cornified envelope and disorganized extracellular lipid matrix, linking PNPLA1 enzymatic activity to cornified envelope formation.\",\n      \"method\": \"Knockout mouse analysis, immunohistochemistry, lipid mass spectrometry, analysis of patient stratum corneum\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — KO mouse and patient tissue with multiple orthogonal readouts\",\n      \"pmids\": [\"28369476\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"ABHD5 (CGI-58) acts as a coactivator of PNPLA1 by physically interacting with PNPLA1 and recruiting it to cytosolic lipid droplets where its triglyceride substrate resides, thereby stimulating PNPLA1-catalyzed acylceramide production; disease-associated ABHD5 missense mutations fail to enhance PNPLA1 activity.\",\n      \"method\": \"Co-immunoprecipitation, cell-based acylceramide production assay, indirect immunofluorescence microscopy, immunoelectron microscopy\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal interaction, localization, and functional assay, replicated independently (PMID:30527376)\",\n      \"pmids\": [\"30361410\", \"30527376\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"ABHD5 co-expression causes PNPLA1 to localize on lipid droplet membranes or their periphery (rather than dispersed in the cytosol); under high co-expression, lipid droplets disappear and appear to transform into vesicles or become incorporated into the ER, suggesting ABHD5 presents triglyceride substrate to PNPLA1.\",\n      \"method\": \"Indirect immunofluorescence microscopy, immunoelectron microscopy in HeLa cells with co-expression system\",\n      \"journal\": \"Journal of dermatological science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — localization data with functional correlation, single lab, two imaging methods\",\n      \"pmids\": [\"30527376\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"PNPLA1 mutations (p.Y245del and p.D172N) in ARCI patient fibroblasts cause abnormal intracellular lipid droplet accumulation associated with decreased LC3 expression and reduced autophagosome formation and autophagosome-lysosome fusion, indicating a role for PNPLA1 in lipophagy-mediated lipid droplet regulation.\",\n      \"method\": \"Fluorescence staining (BODIPY), immunocytochemistry, immunoblotting, siRNA knockdown of PNPLA1 in control fibroblasts\",\n      \"journal\": \"Journal of dermatological science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — patient fibroblasts plus siRNA knockdown, single lab, multiple readouts but mechanism not fully reconstituted\",\n      \"pmids\": [\"30655104\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Fifteen of sixteen tested ichthyosis-associated PNPLA1 missense mutations cause complete loss of acylceramide-producing activity in a cell-based assay; one mutation (C216R) only weakly reduces activity, correlating with milder patient symptoms. Mutants with no activity show variable intracellular localization: some localize to lipid droplets (S19L, D172N), others partially (eight mutants), and five remain cytosolic, indicating that lipid droplet localization is necessary but not sufficient for activity.\",\n      \"method\": \"Cell-based acylceramide production assay with co-overexpression, indirect immunofluorescence microscopy\",\n      \"journal\": \"Journal of dermatological science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — systematic mutagenesis of 16 patient variants with both functional and localization readouts, single lab but comprehensive\",\n      \"pmids\": [\"35970721\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Recombinant truncated PNPLA1 (expressed in E. coli) catalyzes acyl transfer from trilinolein and dilinolein to ω-hydroxyceramide, ω-hydroxyglucosylceramide, and ω-hydroxy acid acceptors, forming acylceramide, glucosyl-acylceramide, and acyl acid respectively; PNPLA1 transfers linoleate with approximately 3:1 selectivity over oleate, explaining in vivo linoleic acid enrichment of acylceramides.\",\n      \"method\": \"In vitro enzyme assay with purified recombinant PNPLA1, liposomal substrates, HPLC-UV and LC-MS product analysis\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with purified recombinant enzyme and defined substrates, substrate selectivity quantified\",\n      \"pmids\": [\"37087101\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"siRNA-mediated knockdown of PNPLA1 in differentiated normal human keratinocytes reduces levels of both LA-esterified and GLA-esterified ceramide 1 subspecies and accumulates non-esterified ω-hydroxy ceramide precursors, demonstrating that PNPLA1 is responsible for esterification of γ-linolenic acid (GLA) as well as linoleic acid to ceramide 1.\",\n      \"method\": \"siRNA knockdown in differentiated normal human keratinocytes, LC-MS lipidomic quantification of ceramide subspecies\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean knockdown with substrate accumulation and product depletion, single lab\",\n      \"pmids\": [\"38340658\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"ABHD5 disease-associated mutations disrupt PNPLA1 function by two distinct mechanisms: (i) mutations in the PNPLA1-binding region of ABHD5 impair PNPLA1 recruitment to lipid droplets; (ii) mutations in potential perilipin-binding domains prevent ABHD5 from associating with lipid droplets, indirectly disrupting PNPLA1 localization. Restoring co-localization of ABHD5 mutants with PNPLA1 in proteoliposomes rescues full PNPLA1 enzyme activity, indicating that spatial proximity (not direct binding) is sufficient for PNPLA1 activation.\",\n      \"method\": \"Analysis of seven ABHD5 missense mutations in cell-based assays, immunofluorescence microscopy, proteoliposome reconstitution assay\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — reconstitution in proteoliposomes plus cell-based localization and activity assays, mechanistic dissection of two distinct pathways\",\n      \"pmids\": [\"40818613\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PNPLA1 is a CoA-independent transacylase expressed specifically in differentiated keratinocytes that catalyzes the final step of ω-O-acylceramide biosynthesis by transferring linoleic acid (with ~3:1 selectivity over oleate) from triglyceride donors to ω-hydroxyceramide acceptors; it is recruited to cytosolic lipid droplets (its substrate reservoir) by the coactivator ABHD5, which stimulates PNPLA1 activity through spatial co-localization rather than obligate direct binding, and loss-of-function mutations in either PNPLA1 or ABHD5 abolish acylceramide production and disrupt the stratum corneum permeability barrier, causing autosomal recessive congenital ichthyosis.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"PNPLA1 is a CoA-independent transacylase expressed specifically in differentiated keratinocytes that catalyzes the final, committed step of ω-O-acylceramide biosynthesis required to build the epidermal permeability barrier [#1, #3]. Working with purified recombinant enzyme, PNPLA1 transfers fatty acid from triglyceride donors (trilinolein and dilinolein) onto ω-hydroxyceramide, ω-hydroxyglucosylceramide, and ω-hydroxy acid acceptors, generating acylceramide, glucosyl-acylceramide, and acyl acid; it selects linoleate over oleate with ~3:1 preference, accounting for the linoleic acid enrichment of epidermal acylceramides, and also esterifies γ-linolenic acid onto ceramide 1 [#8, #9]. In keratinocyte-specific and global Pnpla1 knockout mice, acylceramides and their O-acyl-ω-hydroxy fatty acid components are nearly absent while precursors accumulate, producing a disorganized extracellular lipid matrix, defective lipid coverage of the cornified envelope, and neonatal lethality from barrier failure [#2, #3]. PNPLA1 acquires its triglyceride substrate at cytosolic lipid droplets, to which it is recruited by the coactivator ABHD5 (CGI-58); spatial co-localization of the two proteins at the droplet — rather than obligate direct binding — is sufficient to activate PNPLA1, as shown by proteoliposome reconstitution, and ABHD5 disease mutations abolish activation by impairing either PNPLA1 recruitment or ABHD5's own droplet association [#4, #5, #10]. Loss-of-function mutations in the catalytic domain of PNPLA1 cause autosomal recessive congenital ichthyosis, with the great majority of patient missense variants completely abolishing acylceramide-producing activity [#0, #7].\",\n  \"teleology\": [\n    {\n      \"year\": 2012,\n      \"claim\": \"Established PNPLA1 as a gene essential for the epidermal lipid barrier, answering whether it has a non-redundant role in skin physiology.\",\n      \"evidence\": \"GWAS in dogs and Sanger sequencing of human ARCI patients with histological follow-up\",\n      \"pmids\": [\"22246504\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the biochemical reaction catalyzed\", \"No substrate or product identified\", \"Subcellular site of action unknown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Defined PNPLA1's molecular function as the transacylase catalyzing the final ω-O-esterification step of acylceramide synthesis, linking enzyme activity directly to disease mutations.\",\n      \"evidence\": \"Cell-based and in vitro transacylase assays with recombinant PNPLA1 plus active-site mutagenesis of patient variants, confirmed by KO mouse lipidomics and electron microscopy of lipid lamellae\",\n      \"pmids\": [\"28248318\", \"28248300\", \"28369476\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Source and presentation of the triglyceride substrate not yet defined\", \"Acceptor substrate range incompletely mapped\", \"Fatty acid selectivity not quantified\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identified ABHD5 (CGI-58) as the coactivator that recruits PNPLA1 to lipid droplets, answering how the enzyme accesses its triglyceride substrate.\",\n      \"evidence\": \"Co-immunoprecipitation, cell-based acylceramide assays, and immunofluorescence/immunoelectron microscopy in co-expression systems\",\n      \"pmids\": [\"30361410\", \"30527376\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether direct binding or spatial proximity drives activation not resolved\", \"Mechanism of triglyceride presentation inferred from imaging only\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Proposed an additional role for PNPLA1 in lipophagy-mediated lipid droplet turnover, raising the question of whether barrier defects involve autophagy.\",\n      \"evidence\": \"BODIPY staining, immunoblotting, and siRNA knockdown in ARCI patient and control fibroblasts\",\n      \"pmids\": [\"30655104\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism not reconstituted; autophagy link is correlative\", \"Relationship to transacylase activity unclear\", \"Observed in fibroblasts rather than keratinocytes\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Systematically tied PNPLA1 patient variants to loss of catalytic activity and showed lipid droplet localization is necessary but not sufficient for activity.\",\n      \"evidence\": \"Cell-based acylceramide assay and immunofluorescence across sixteen ichthyosis-associated missense mutations\",\n      \"pmids\": [\"35970721\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Single-lab dataset\", \"Structural basis for activity loss not determined\", \"Why some inactive mutants still localize to droplets unexplained\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Reconstituted PNPLA1 transacylase activity with purified enzyme and defined substrates, quantifying its ~3:1 linoleate-over-oleate selectivity and broad acceptor range.\",\n      \"evidence\": \"In vitro assays with E. coli-expressed truncated recombinant PNPLA1, liposomal substrates, and HPLC-UV/LC-MS product analysis\",\n      \"pmids\": [\"37087101\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Used truncated enzyme rather than full-length\", \"Structural determinants of fatty acid selectivity not defined\", \"Role of ABHD5 in the purified system not tested here\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Extended PNPLA1's acceptor/donor scope to γ-linolenic acid esterification of ceramide 1 in human keratinocytes, broadening its substrate repertoire beyond linoleic acid.\",\n      \"evidence\": \"siRNA knockdown in differentiated normal human keratinocytes with LC-MS lipidomic quantification of ceramide subspecies\",\n      \"pmids\": [\"38340658\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab knockdown study\", \"Relative physiological contribution of GLA vs LA esterification unquantified\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Resolved the mechanism of ABHD5 activation, showing spatial proximity rather than direct binding is sufficient to activate PNPLA1 and dissecting two distinct mutational failure modes.\",\n      \"evidence\": \"Cell-based assays and immunofluorescence of seven ABHD5 missense mutations plus proteoliposome reconstitution rescuing PNPLA1 activity by restoring co-localization\",\n      \"pmids\": [\"40818613\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular details of substrate hand-off at the droplet surface remain undefined\", \"Role of perilipins in droplet targeting inferred, not directly tested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A high-resolution structural model of PNPLA1, its catalytic mechanism, and the geometry of triglyceride/ceramide substrate engagement at the lipid droplet interface remain to be established.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No experimental structure of PNPLA1\", \"Structural basis of linoleate selectivity unknown\", \"How autophagy/lipophagy role integrates with transacylase function unresolved\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [1, 2, 8, 9]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [1, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005811\", \"supporting_discovery_ids\": [4, 5, 7]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [5, 7]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [1, 2, 8]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 2, 3]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"ABHD5\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":5,"faith_pct":100.0}}